We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current LABD market cap is 14.94M. The company's latest EPS is USD 17.6028 and P/E is 0.37.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.28M | 918k | 14k | 1.71M | 5.18M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -25.21M | -91.4M | -85.56M | -16.59M | 40.77M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 October 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.98M | 82.7M | 50.85M | 222.42M | 87.97M |
| Total Liabilities | 3.64M | 19.14M | 3.59M | 32.45M | 26.05M |
| Total Equity | 82.34M | 63.56M | 47.27M | 189.98M | 61.92M |
| Market Cap | 14.94M |
| Price to Earnings Ratio | 0.37 |
| Price to Sales Ratio | 2.88 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0.24 |
| Dividend Yield | - |
| Shares Outstanding | 2.32M |
| Average Volume (1 week) | 23.08M |
| Average Volume (1 Month) | 20.98M |
| 52 Week Change | -43.72% |
| 52 Week High | 12.46 |
| 52 Week Low | 4.78 |
| Spread (Intraday) | 0.07 (1.09%) |
| Company Name | Direxion Daily S&P Biotech Bear 3X Shares |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https:// |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
